BACKGROUND: Liver transplantation offers life-saving therapy for patients with decompensated liver disease or T2 hepatocellular carcinomas. In the United States, deceased donor livers are primarily allocated by Model for End-Stage Liver Disease (MELD) score within each of the country's more than 50 donation service areas (DSAs). Variation in DSA size, population, and organ availability have engendered concern that unequal access to deceased donor livers across DSAs contributes to geographic variability in outcome. METHODS: To determine the extent to which DSA variability in organ availability correlated with combined waitlist and posttransplant mortality, we analyzed retrospectively national waitlist and posttransplant data for a 7-year period after implementation of the current MELD-based allocation system. RESULTS: Marked variation among DSAs was evident in death rate (3.3-fold), transplant rate (20-fold), and mean transplant MELD (>10 points). Death rate correlated with organ availability was assessed by transplant rate and transplant MELD. DSAs with low organ availability included the country's largest cities, had more new listings per capita, larger waitlists, more transplant centers per DSA, and a higher proportion of black and Asian patients. DSAs of organ shortage were also characterized by more frequent dual listing at another transplant center, more living donor liver transplants, and increased average length of the transplant admission. CONCLUSIONS: Geographic differences in deceased donor organ availability contribute to variation in overall death rate of liver transplant patients, shape the clinical practice of transplant, and influence the resources consumed per transplant. Geographic variation in organ access results primarily from rates of listing rather than donation. Our findings highlight the need to restructure organ distribution areas to achieve equal access to deceased donor livers for transplantation in the United States.
BACKGROUND: Liver transplantation offers life-saving therapy for patients with decompensated liver disease or T2 hepatocellular carcinomas. In the United States, deceased donor livers are primarily allocated by Model for End-Stage Liver Disease (MELD) score within each of the country's more than 50 donation service areas (DSAs). Variation in DSA size, population, and organ availability have engendered concern that unequal access to deceased donor livers across DSAs contributes to geographic variability in outcome. METHODS: To determine the extent to which DSA variability in organ availability correlated with combined waitlist and posttransplant mortality, we analyzed retrospectively national waitlist and posttransplant data for a 7-year period after implementation of the current MELD-based allocation system. RESULTS: Marked variation among DSAs was evident in death rate (3.3-fold), transplant rate (20-fold), and mean transplant MELD (>10 points). Death rate correlated with organ availability was assessed by transplant rate and transplant MELD. DSAs with low organ availability included the country's largest cities, had more new listings per capita, larger waitlists, more transplant centers per DSA, and a higher proportion of black and Asian patients. DSAs of organ shortage were also characterized by more frequent dual listing at another transplant center, more living donor liver transplants, and increased average length of the transplant admission. CONCLUSIONS: Geographic differences in deceased donor organ availability contribute to variation in overall death rate of liver transplant patients, shape the clinical practice of transplant, and influence the resources consumed per transplant. Geographic variation in organ access results primarily from rates of listing rather than donation. Our findings highlight the need to restructure organ distribution areas to achieve equal access to deceased donor livers for transplantation in the United States.
Authors: T E Starzl; R D Gordon; A Tzakis; S Staschak; V Fioravanti; B Broznick; L Makowka; H T Bahnson Journal: Transplant Proc Date: 1988-02 Impact factor: 1.066
Authors: P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim Journal: Hepatology Date: 2001-02 Impact factor: 17.425
Authors: Niraj M Desai; Kevin C Mange; Michael D Crawford; Peter L Abt; Adam M Frank; Joseph W Markmann; Ergun Velidedeoglu; William C Chapman; James F Markmann Journal: Transplantation Date: 2004-01-15 Impact factor: 4.939
Authors: Sammy Saab; Victor Wang; Ayman B Ibrahim; Francisco Durazo; Steven Han; Douglas G Farmer; Hasan Yersiz; Marcia Morrisey; Leonard I Goldstein; R Mark Ghobrial; Ronald W Busuttil Journal: Liver Transpl Date: 2003-05 Impact factor: 5.799
Authors: Mathew Jacob; Lynn P Copley; James D Lewsey; Alex Gimson; Giles J Toogood; Mohamed Rela; Jan H P van der Meulen Journal: Liver Transpl Date: 2004-07 Impact factor: 5.799
Authors: Richard B Freeman; Russell H Wiesner; Erick Edwards; Ann Harper; Robert Merion; Robert Wolfe Journal: Liver Transpl Date: 2004-01 Impact factor: 5.799
Authors: Andrew Wey; Joshua Pyke; David P Schladt; Sommer E Gentry; Tim Weaver; Nicholas Salkowski; Bertram L Kasiske; Ajay K Israni; Jon J Snyder Journal: Liver Transpl Date: 2018-04 Impact factor: 5.799
Authors: Douglas R Murken; Allison W Peng; David D Aufhauser; Peter L Abt; David S Goldberg; Matthew H Levine Journal: Liver Transpl Date: 2017-06 Impact factor: 5.799
Authors: Mary G Bowring; Sheng Zhou; Eric K H Chow; Allan B Massie; Dorry L Segev; Sommer E Gentry Journal: Transplantation Date: 2019-10 Impact factor: 4.939
Authors: Christine E Haugen; Tanveen Ishaque; Abel Sapirstein; Alexander Cauneac; Dorry L Segev; Sommer Gentry Journal: Am J Transplant Date: 2019-03-18 Impact factor: 8.086
Authors: Sommer E Gentry; Eric K H Chow; Allan Massie; Xun Luo; David Zaun; Jon J Snyder; Ajay K Israni; Bert Kasiske; Dorry L Segev Journal: Liver Transpl Date: 2015-03 Impact factor: 5.799
Authors: Cory R Schaffhausen; Marilyn J Bruin; Sauman Chu; Helen Fu; Warren T McKinney; David Schladt; Jon J Snyder; W Ray Kim; Jack R Lake; Bertram L Kasiske; Ajay K Israni Journal: Liver Transpl Date: 2020-03 Impact factor: 5.799